Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1968 7
1969 10
1970 3
1971 7
1972 13
1973 12
1974 10
1975 17
1976 10
1977 4
1978 3
1979 8
1981 3
1982 7
1983 7
1984 2
1985 7
1986 5
1987 6
1988 4
1989 5
1990 5
1991 7
1992 13
1993 17
1994 8
1995 13
1996 6
1997 8
1998 8
1999 8
2000 10
2001 12
2002 16
2003 5
2004 13
2005 25
2006 30
2007 31
2008 28
2009 48
2010 36
2011 39
2012 40
2013 53
2014 49
2015 59
2016 62
2017 66
2018 74
2019 73
2020 51
2021 34
2022 13
2023 17
2024 46
2025 53
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,126 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for and abo ad
Search for Andabo AD instead (1 results)
Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice.
Scaglione F. Scaglione F. Toxins (Basel). 2016 Mar 4;8(3):65. doi: 10.3390/toxins8030065. Toxins (Basel). 2016. PMID: 26959061 Free PMC article. Review.
A higher conversion ratio may lead to an overdosing of ABO. While uncommon, distant spread may occur; however, several factors other than the pharmaceutical preparation are thought to affect spread. Finally, whereas the three products have similar efficacy when properly do …
A higher conversion ratio may lead to an overdosing of ABO. While uncommon, distant spread may occur; however, several factors other …
ABO-Incompatible Liver Transplantation - A Review of the Historical Background and Results.
Dahlgren US, Bennet W. Dahlgren US, et al. Int Rev Immunol. 2019;38(3):118-128. doi: 10.1080/08830185.2019.1601720. Epub 2019 Apr 23. Int Rev Immunol. 2019. PMID: 31012340 Review.
ABO-incompatible liver transplantation (ABOi LT) using conventional immunosuppression has been considered a contraindication due to the high risk for antibody-mediated complications potentially resulting in graft loss. ...We also discuss the remaining hurdles and future st …
ABO-incompatible liver transplantation (ABOi LT) using conventional immunosuppression has been considered a contraindication due to t …
Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
Masutani K, Tsuchimoto A, Kurihara K, Okabe Y, Kitada H, Okumi M, Tanabe K, Nakamura M, Kitazono T, Tsuruya K; Japan Academic Consortium of Kidney Transplantation (JACK) investigators. Masutani K, et al. Transplantation. 2017 Jun;101(6):1416-1422. doi: 10.1097/TP.0000000000001324. Transplantation. 2017. PMID: 27391195
BACKGROUND: ABO-incompatible (ABO-I) kidney transplantation (KTx) is an established procedure to expand living donor sources. Although graft and patient survival rates are comparable between ABO-compatible (ABO-C) and ABO-I KTx, several studies …
BACKGROUND: ABO-incompatible (ABO-I) kidney transplantation (KTx) is an established procedure to expand living donor sources. …
The European experience.
Tydén G. Tydén G. Transplantation. 2007 Dec 27;84(12 Suppl):S2-3. doi: 10.1097/01.tp.0000296007.08413.75. Transplantation. 2007. PMID: 18162981
A new protocol for ABO-incompatible kidney transplantation was introduced in 2001. In this protocol, antigen-specific immunoadsorption to remove existing AB antibodies is used in addition to rituximab to prevent rebound of antibodies and conventional immunosuppression (tac …
A new protocol for ABO-incompatible kidney transplantation was introduced in 2001. In this protocol, antigen-specific immunoadsorptio …
Living donor liver transplantation using ABO-incompatible grafts for chronic and acute liver failure.
Ikegami T, Tsunematsu M, Furukawa K, Onda S, Matsumoto M, Shirai Y, Haruki K. Ikegami T, et al. Surg Today. 2025 Oct;55(10):1347-1352. doi: 10.1007/s00595-025-03100-3. Epub 2025 Jul 22. Surg Today. 2025. PMID: 40691743 Review.
The introduction of rituximab, an anti-CD20 antibody, has changed the treatment strategies and outcomes for ABO-incompatible living donor liver transplantation (ABOi-LDLT) dramatically. Rituximab targets the CD20-positive B-cells that would differentiate into plasma cells, …
The introduction of rituximab, an anti-CD20 antibody, has changed the treatment strategies and outcomes for ABO-incompatible living d …
A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
Kim SH, Lee EC, Shim JR, Park SJ. Kim SH, et al. Liver Int. 2018 May;38(5):932-939. doi: 10.1111/liv.13614. Epub 2017 Oct 31. Liver Int. 2018. PMID: 29053910
The outcomes were compared with those of ABO-C LDLT by 1:2 propensity score-matched analysis. RESULTS: Consecutive 43 ABO-I LDLT patients were identified between 2014 and 2016. ...Biliary stricture was the most common complication with an incidence of 30.2%. A compa …
The outcomes were compared with those of ABO-C LDLT by 1:2 propensity score-matched analysis. RESULTS: Consecutive 43 ABO-I LD …
Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence.
Henrichs KF, Howk N, Masel DS, Thayer M, Refaai MA, Kirkley SA, Heal JM, Blumberg N. Henrichs KF, et al. Transfusion. 2012 Mar;52(3):635-40. doi: 10.1111/j.1537-2995.2011.03329.x. Epub 2011 Sep 2. Transfusion. 2012. PMID: 21895675 Free PMC article. Clinical Trial.
BACKGROUND: There are multiple benefits to transfusing only ABO-identical blood components. Historically our institution routinely transfused ABO-nonidentical platelets (PLTs) and cryoprecipitate to surgical patients. ...A progressive reduction in de novo RBC alloim …
BACKGROUND: There are multiple benefits to transfusing only ABO-identical blood components. Historically our institution routinely tr …
1,126 results